Osnabrueck, Germany

Frank Seela

USPTO Granted Patents = 24 

 

 

Average Co-Inventor Count = 2.6

ph-index = 10

Forward Citations = 362(Granted Patents)


Location History:

  • Paderborn, DE (1989 - 2001)
  • Osnabruck, DE (1995 - 2001)
  • Osnabr{umlaut over (u)}ck, DE (2001)
  • Osnabrück, DE (2001 - 2006)
  • Osnabrueck, DE (1998 - 2015)

Company Filing History:


Years Active: 1989-2015

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):

Title: **Frank Seela: Innovator in Nucleic Acid Binding Technologies**

Introduction

Frank Seela, based in Osnabrueck, Germany, is a distinguished inventor with a remarkable portfolio that includes 24 patents. His contributions to the field of molecular biology, particularly in the area of nucleic acid binding compounds, have proven invaluable for diagnostics and therapeutic applications.

Latest Patents

Among his latest innovations, Seela has developed a conjugate that features a thiophilic solid phase linked to an oligonucleotide containing a thiooxonucleotide. This groundbreaking work allows for more efficient binding and detection of nucleic acids. Another notable patent involves nucleic acid binding compounds that incorporate pyrazolo[3,4-D]pyrimidine analogues of purin-2,6-diamine, which have significant implications for the determination and analysis of nucleic acids in diagnostic settings.

Career Highlights

Throughout his career, Frank Seela has made substantial contributions while working at prominent companies such as Roche Diagnostics GmbH and Roche Molecular Systems, Inc. His work has led to advancements in diagnostics and has fostered a deeper understanding of nucleic acid interactions.

Collaborations

Seela has collaborated with notable colleagues, including Herbert von der Eltz and Dieter Heindl. These partnerships have strengthened his research efforts and broadened the impact of his inventions in the scientific community.

Conclusion

Frank Seela's dedication to innovation in nucleic acid technologies continues to drive progress in the field. His impressive array of patents reflects his commitment to enhancing diagnostic methods and the understanding of molecular interactions. With ongoing contributions, he remains a significant figure in the world of scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…